These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38286744)

  • 1. Association of biofilm formation, antimicrobial resistance, clinical characteristics, and clinical outcomes among Acinetobacter baumannii isolates from patients with ventilator-associated pneumonia.
    Chukamnerd A; Saipetch N; Singkhamanan K; Ingviya N; Assanangkornchai N; Surachat K; Chusri S
    Clin Respir J; 2024 Jan; 18(1):e13732. PubMed ID: 38286744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance and biofilm formation capacity among Acinetobacter baumannii strains isolated from patients with burns and ventilator-associated pneumonia.
    Khoshnood S; Sadeghifard N; Mahdian N; Heidary M; Mahdian S; Mohammadi M; Maleki A; Haddadi MH
    J Clin Lab Anal; 2023 Jan; 37(1):e24814. PubMed ID: 36573013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilm formation is not an independent risk factor for mortality in patients with
    Chiang TT; Huang TW; Sun JR; Kuo SC; Cheng A; Liu CP; Liu YM; Yang YS; Chen TL; Lee YT; Wang YC
    Front Cell Infect Microbiol; 2022; 12():964539. PubMed ID: 36189355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.
    Le Minh V; Thi Khanh Nhu N; Vinh Phat V; Thompson C; Huong Lan NP; Thieu Nga TV; Thanh Tam PT; Tuyen HT; Hoang Nhu TD; Van Hao N; Thi Loan H; Minh Yen L; Parry CM; Trung Nghia HD; Campbell JI; Hien TT; Thwaites L; Thwaites G; Van Vinh Chau N; Baker S
    J Med Microbiol; 2015 Oct; 64(10):1162-1169. PubMed ID: 26297024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
    Dizbay M; Altuncekic A; Sezer BE; Ozdemir K; Arman D
    Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
    Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
    Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial.
    Nowak J; Zander E; Stefanik D; Higgins PG; Roca I; Vila J; McConnell MJ; Cisneros JM; Seifert H;
    J Antimicrob Chemother; 2017 Dec; 72(12):3277-3282. PubMed ID: 28961773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
    Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptations of carbapenem resistant
    Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
    [No Abstract]   [Full Text] [Related]  

  • 14. Acinetobacter baumannii in suspected bacterial infections: Association between multidrug resistance, virulence genes, & biofilm production.
    Gautam D; Dolma KG; Khandelwal B; Goyal RK; Mitsuwan W; Pereira MLG; Klangbud WK; Gupta M; Wilairatana P; Siyadatpanah A; Wiart C; Nissapatorn V
    Indian J Med Res; 2023 Oct; 158(4):439-446. PubMed ID: 38006347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics.
    Schuertz KF; Tuon FF; Palmeiro JK; Conte D; Telles JPM; Trevisoli LE; Dalla-Costa LM
    Braz J Microbiol; 2018 Nov; 49 Suppl 1(Suppl 1):199-204. PubMed ID: 29720352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA).
    Al-Obeid S; Jabri L; Al-Agamy M; Al-Omari A; Shibl A
    J Chemother; 2015 Jun; 27(3):156-62. PubMed ID: 25867622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
    Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone resistance conferred by gyrA, parC mutations, and AbaQ efflux pump among Acinetobacter baumannii clinical isolates causing ventilator-associated pneumonia.
    Attia NM; Elbaradei A
    Acta Microbiol Immunol Hung; 2019 Dec; 67(4):234-238. PubMed ID: 31833383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.
    Álvarez-Marín R; López-Rojas R; Márquez JA; Gómez MJ; Molina J; Cisneros JM; Ortiz-Leyba C; Aznar J; Garnacho-Montero J; Pachón J
    PLoS One; 2016; 11(12):e0168468. PubMed ID: 27992528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.